Abstract
With the advent of new technologies, a large amount of biological data is easily generated in comparatively cheaper cost. Prior to this data integration was done by simple means of database addition, with less complexity due to lesser data generated in a standardized format. Understanding a complete biological phenomenon, such as disease, need a comprehensive understanding of many dimensions associated with it. This information cannot be captured in a single data type format. Mandating the use of a single data type study would leave us with incomplete answers to various biological questions. Thus the development of an effective integration technique with effective visualization platform is the need of the hour. One such framework requires the identification of relevant data from the input system, storing and transforming data into the intermediary level and then mapping these data into an appropriate position in the output systems. This intermediate level helps in reducing the number of connection and repeated specification creation. Integration of drug dataset would not only reduce the propagation of incorrect and not-updated medicinal information among doctors, but it would also help build better treatment strategies. Integration of drug data and visualization technique would be a novel approach to study drugs and effect on one platform. In this work, we tried to integrate the Adverse Effects, Drug Enforcement and Drug Label data from openFDA. This integrated database is coupled with a visualization platform IDEALS, an abbreviation for Integrated Drug Events, Adverse Effect and Label System.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.